Answers are grounded in this paper and cite their sources.
Experimental study demonstrates selective fluorescent labeling of amyloid-β plaques in 5XFAD mouse brain tissue using indolizine probes, highlighting their utility for multichannel imaging.
Fluorescence probes for visualizing amyloid-β (Aβ) plaques are important tools in Alzheimer’s disease (AD) research. We synthesized a library of 49 indolizine derivatives using a modular synthetic approach and evaluated their fluorescence labeling behavior directly in ex vivo brain tissue sections from 5XFAD transgenic mice. Through an ex vivo tissue-based screening workflow using anti-Aβ antibody 6E10 as a reference standard for plaque-containing regions, five hit compounds (YIZ-20, YIZ-32, YIZ-36, YIZ-45, and YIZ-47) displaying plaque-associated fluorescence patterns were identified. Costaining experiments demonstrated spatial correspondence between probe fluorescence and antibody-defined plaque regions. Spectral analysis showed that the selected YIZ probes exhibited emission profiles with somewhat reduced overlap with the Hoechst 33342 channel compared with thioflavin S (ThS), providing a modest but practical advantage for multichannel imaging applications. These findings highlight the utility of ex vivo tissue-based screening for fluorescent-probe discovery and establish indolizine as a promising scaffold for the development of complementary fluorescence imaging tools for AD-related ex vivo tissue studies.
No takes yet. Share an insight, caveat, or question.
Park et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: